Showing results (381-390 of 438) with videos related to
Sort By:
Pageof 44
American Heart Journal|April 30, 2017
Differential occurrence, profile, and impact of first recurrent cardiovascular events after an acute coronary syndromeConnie N Hess, Robert M Clare, Megan L Neely, et al.JACC. Cardiovascular Interventions|June 9, 2022
Clinical Outcomes in Patients With ST-Segment Elevation MI and No Standard Modifiable Cardiovascular Risk FactorsGemma A Figtree, Bjorn Redfors, Rebecca Kozor, et al.Clinical Cardiology|July 29, 2016
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS TrialLarry R Jackson, Jonathan P Piccini, Derek D Cyr, et al.American Heart Journal|September 26, 2006
The impact of emergency department structure and care processes in delivering care for non-ST-segment elevation acute coronary syndromesRajendra H Mehta, L Kristin Newby, Yogin Patel, et al.American Heart Journal|April 1, 2009
Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patients: The Complications After Thrombocytopenia Caused by Heparin (CATCH) registryEric M Crespo, Gustavo B F Oliveira, Emily F Honeycutt, et al.European Heart Journal|April 3, 2009
Prior polyvascular disease: risk factor for adverse ischaemic outcomes in acute coronary syndromesDeepak L Bhatt, Eric D Peterson, Robert A Harrington, et al.International Journal of Cardiology|February 21, 2012
Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 yearsMark Y Chan, Jie-Lena Sun, L Kristin Newby, et al.Scientific Reports|April 12, 2020
Circulating MicroRNA Profiling in Non-ST Elevated Coronary Artery Syndrome Highlights Genomic Associations with Serial Platelet Reactivity MeasurementsKristian C Becker, Lydia Coulter Kwee, Megan L Neely, et al.Journal of the American College of Cardiology|March 19, 2016
Spontaneous MI After Non-ST-Segment Elevation Acute Coronary Syndrome Managed Without Revascularization: The TRILOGY ACS TrialRenato D Lopes, Sergio Leonardi, Benjamin Neely, et al.Circulation|September 18, 2002
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, and EptifibatideWayne B Batchelor, Thaddeus R Tolleson, Yao Huang, et al.Pageof 44